Tetanus vaccine, also known as tetanus toxoid (TT), is an inactive vaccine used to prevent tetanus. During childhood five doses are recommended, with a sixth given during adolescence. Additional doses every 10 years are recommended. After three doses almost everyone is initially immune. In those who are not up to date on their tetanus immunization a booster should be given within 48 hours of an injury. In those with high risk injuries who are not fully immunized tetanus antitoxin may also be recommended. Making sure women who are pregnant are up to date on their tetanus immunization and, if not, immunizing them can prevent neonatal tetanus.
The vaccine is very safe including during pregnancy and in those with HIV/AIDS. Redness and pain at the site of injection occur in between 25% and 85% of people. Fever, feeling tired, and minor muscles pains occur in less than 10% of people. Severe allergic reactions occur in less than one in 100,000 people.
A number of vaccine combinations include the tetanus vaccine such as DTaP and Tdap which contain diphtheria, tetanus, and pertussis vaccine, and DT and Td which contain diphtheria and tetanus vaccine. DTaP and DT are given to children less than seven years old while Tdap and Td are given to those seven years old and older. The lowercase d and p denote lower strengths of diphtheria and pertussis vaccines.
The tetanus vaccine was developed in 1924 and became available in the United States in the 1940s. Its use resulted in a 95% decrease in the rate of tetanus. It is on the World Health Organization's List of Essential Medicines, the most effective and safe medicines needed in a health system. The wholesale cost in the developing world is between 0.17 and 0.65 USD per dose as of 2014.In the United States a course of tetanus vaccine is between 25 and 50 USD.
The global Tetanus Vaccine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Tetanus Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Tetanus Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Tetanus Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Tetanus Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Tetanus Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Tetanus Vaccine sales, projected growth trends, production technology, application and end-user industry.
麻豆原创 Segmentation
By Company
Merck & Co.,Inc
Sanofi Pasteur SA
Biological E
Dano Vaccine &Biological Pvt.Ltd.,
Panera
Shantha Biotechnics Ltd
Segment by Type
Diphtheria and tetanus (DT) vaccines
Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines
Tetanus and diphtheria (Td) vaccines
Tetanus, diphtheria, and pertussis (Tdap) vaccines
Segment by Application
Adult
Pediatric
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Tetanus Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Tetanus Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Tetanus Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 Tetanus Vaccine Product Introduction
1.2 麻豆原创 by Type
1.2.1 Global Tetanus Vaccine 麻豆原创 Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Diphtheria and tetanus (DT) vaccines
1.2.3 Diphtheria, tetanus, and pertussis (whooping cough) (DTaP) vaccines
1.2.4 Tetanus and diphtheria (Td) vaccines
1.2.5 Tetanus, diphtheria, and pertussis (Tdap) vaccines
1.3 麻豆原创 by Application
1.3.1 Global Tetanus Vaccine 麻豆原创 Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Adult
1.3.3 Pediatric
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Tetanus Vaccine Sales Estimates and Forecasts 2019-2030
2.2 Global Tetanus Vaccine Revenue by Region
2.2.1 Global Tetanus Vaccine Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Tetanus Vaccine Revenue by Region (2019-2024)
2.2.3 Global Tetanus Vaccine Revenue by Region (2025-2030)
2.2.4 Global Tetanus Vaccine Revenue 麻豆原创 Share by Region (2019-2030)
2.3 Global Tetanus Vaccine Sales Estimates and Forecasts 2019-2030
2.4 Global Tetanus Vaccine Sales by Region
2.4.1 Global Tetanus Vaccine Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Tetanus Vaccine Sales by Region (2019-2024)
2.4.3 Global Tetanus Vaccine Sales by Region (2025-2030)
2.4.4 Global Tetanus Vaccine Sales 麻豆原创 Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Tetanus Vaccine Sales by Manufacturers
3.1.1 Global Tetanus Vaccine Sales by Manufacturers (2019-2024)
3.1.2 Global Tetanus Vaccine Sales 麻豆原创 Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Tetanus Vaccine in 2023
3.2 Global Tetanus Vaccine Revenue by Manufacturers
3.2.1 Global Tetanus Vaccine Revenue by Manufacturers (2019-2024)
3.2.2 Global Tetanus Vaccine Revenue 麻豆原创 Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Tetanus Vaccine Revenue in 2023
3.3 Global Key Players of Tetanus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Tetanus Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers 麻豆原创 Concentration Ratio (CR5 and HHI)
3.5.2 Global Tetanus Vaccine 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Tetanus Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Tetanus Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Tetanus Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 麻豆原创 Size by Type
4.1 Global Tetanus Vaccine Sales by Type
4.1.1 Global Tetanus Vaccine Historical Sales by Type (2019-2024)
4.1.2 Global Tetanus Vaccine Forecasted Sales by Type (2025-2030)
4.1.3 Global Tetanus Vaccine Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Tetanus Vaccine Revenue by Type
4.2.1 Global Tetanus Vaccine Historical Revenue by Type (2019-2024)
4.2.2 Global Tetanus Vaccine Forecasted Revenue by Type (2025-2030)
4.2.3 Global Tetanus Vaccine Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Tetanus Vaccine Price by Type
4.3.1 Global Tetanus Vaccine Price by Type (2019-2024)
4.3.2 Global Tetanus Vaccine Price Forecast by Type (2025-2030)
5 麻豆原创 Size by Application
5.1 Global Tetanus Vaccine Sales by Application
5.1.1 Global Tetanus Vaccine Historical Sales by Application (2019-2024)
5.1.2 Global Tetanus Vaccine Forecasted Sales by Application (2025-2030)
5.1.3 Global Tetanus Vaccine Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Tetanus Vaccine Revenue by Application
5.2.1 Global Tetanus Vaccine Historical Revenue by Application (2019-2024)
5.2.2 Global Tetanus Vaccine Forecasted Revenue by Application (2025-2030)
5.2.3 Global Tetanus Vaccine Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Tetanus Vaccine Price by Application
5.3.1 Global Tetanus Vaccine Price by Application (2019-2024)
5.3.2 Global Tetanus Vaccine Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Tetanus Vaccine 麻豆原创 Size by Type
6.1.1 US & Canada Tetanus Vaccine Sales by Type (2019-2030)
6.1.2 US & Canada Tetanus Vaccine Revenue by Type (2019-2030)
6.2 US & Canada Tetanus Vaccine 麻豆原创 Size by Application
6.2.1 US & Canada Tetanus Vaccine Sales by Application (2019-2030)
6.2.2 US & Canada Tetanus Vaccine Revenue by Application (2019-2030)
6.3 US & Canada Tetanus Vaccine 麻豆原创 Size by Country
6.3.1 US & Canada Tetanus Vaccine Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Tetanus Vaccine Sales by Country (2019-2030)
6.3.3 US & Canada Tetanus Vaccine Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Tetanus Vaccine 麻豆原创 Size by Type
7.1.1 Europe Tetanus Vaccine Sales by Type (2019-2030)
7.1.2 Europe Tetanus Vaccine Revenue by Type (2019-2030)
7.2 Europe Tetanus Vaccine 麻豆原创 Size by Application
7.2.1 Europe Tetanus Vaccine Sales by Application (2019-2030)
7.2.2 Europe Tetanus Vaccine Revenue by Application (2019-2030)
7.3 Europe Tetanus Vaccine 麻豆原创 Size by Country
7.3.1 Europe Tetanus Vaccine Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Tetanus Vaccine Sales by Country (2019-2030)
7.3.3 Europe Tetanus Vaccine Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Tetanus Vaccine 麻豆原创 Size
8.1.1 China Tetanus Vaccine Sales (2019-2030)
8.1.2 China Tetanus Vaccine Revenue (2019-2030)
8.2 China Tetanus Vaccine 麻豆原创 Size by Application
8.2.1 China Tetanus Vaccine Sales by Application (2019-2030)
8.2.2 China Tetanus Vaccine Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Tetanus Vaccine 麻豆原创 Size by Type
9.1.1 Asia Tetanus Vaccine Sales by Type (2019-2030)
9.1.2 Asia Tetanus Vaccine Revenue by Type (2019-2030)
9.2 Asia Tetanus Vaccine 麻豆原创 Size by Application
9.2.1 Asia Tetanus Vaccine Sales by Application (2019-2030)
9.2.2 Asia Tetanus Vaccine Revenue by Application (2019-2030)
9.3 Asia Tetanus Vaccine Sales by Region
9.3.1 Asia Tetanus Vaccine Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Tetanus Vaccine Revenue by Region (2019-2030)
9.3.3 Asia Tetanus Vaccine Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Tetanus Vaccine 麻豆原创 Size by Type
10.1.1 Middle East, Africa and Latin America Tetanus Vaccine Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Tetanus Vaccine Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Tetanus Vaccine 麻豆原创 Size by Application
10.2.1 Middle East, Africa and Latin America Tetanus Vaccine Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Tetanus Vaccine Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Tetanus Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Tetanus Vaccine Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Tetanus Vaccine Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Tetanus Vaccine Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 GlaxoSmithKline plc
11.1.1 GlaxoSmithKline plc Company Information
11.1.2 GlaxoSmithKline plc Overview
11.1.3 GlaxoSmithKline plc Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 GlaxoSmithKline plc Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 GlaxoSmithKline plc Recent Developments
11.2 Pfizer,Inc
11.2.1 Pfizer,Inc Company Information
11.2.2 Pfizer,Inc Overview
11.2.3 Pfizer,Inc Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Pfizer,Inc Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Pfizer,Inc Recent Developments
11.3 Merck & Co.,Inc
11.3.1 Merck & Co.,Inc Company Information
11.3.2 Merck & Co.,Inc Overview
11.3.3 Merck & Co.,Inc Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Merck & Co.,Inc Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck & Co.,Inc Recent Developments
11.4 Sanofi Pasteur SA
11.4.1 Sanofi Pasteur SA Company Information
11.4.2 Sanofi Pasteur SA Overview
11.4.3 Sanofi Pasteur SA Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Sanofi Pasteur SA Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sanofi Pasteur SA Recent Developments
11.5 Biological E
11.5.1 Biological E Company Information
11.5.2 Biological E Overview
11.5.3 Biological E Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Biological E Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Biological E Recent Developments
11.6 Dano Vaccine &Biological Pvt.Ltd.,
11.6.1 Dano Vaccine &Biological Pvt.Ltd., Company Information
11.6.2 Dano Vaccine &Biological Pvt.Ltd., Overview
11.6.3 Dano Vaccine &Biological Pvt.Ltd., Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Dano Vaccine &Biological Pvt.Ltd., Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Dano Vaccine &Biological Pvt.Ltd., Recent Developments
11.7 Panera
11.7.1 Panera Company Information
11.7.2 Panera Overview
11.7.3 Panera Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Panera Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Panera Recent Developments
11.8 Shantha Biotechnics Ltd
11.8.1 Shantha Biotechnics Ltd Company Information
11.8.2 Shantha Biotechnics Ltd Overview
11.8.3 Shantha Biotechnics Ltd Tetanus Vaccine Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Shantha Biotechnics Ltd Tetanus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Shantha Biotechnics Ltd Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Tetanus Vaccine Industry Chain Analysis
12.2 Tetanus Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Tetanus Vaccine Production Mode & Process
12.4 Tetanus Vaccine Sales and 麻豆原创ing
12.4.1 Tetanus Vaccine Sales Channels
12.4.2 Tetanus Vaccine Distributors
12.5 Tetanus Vaccine Customers
13 麻豆原创 Dynamics
13.1 Tetanus Vaccine Industry Trends
13.2 Tetanus Vaccine 麻豆原创 Drivers
13.3 Tetanus Vaccine 麻豆原创 Challenges
13.4 Tetanus Vaccine 麻豆原创 Restraints
14 Key Findings in The Global Tetanus Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
GlaxoSmithKline plc
Pfizer,Inc
Merck & Co.,Inc
Sanofi Pasteur SA
Biological E
Dano Vaccine &Biological Pvt.Ltd.,
Panera
Shantha Biotechnics Ltd
听
听
*If Applicable.